Mostrando 2 resultados de: 2
Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences–Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting
ArticleAbstract: Purpose: The symposium Health and Medicines in Indigenous Populations of America was organized by thPalabras claves:CIOMS-RIBEF, clinical research, pharmacogenetics, resource-limited settingsAutores:Adrián LLerena, Diwakar S., Enrique Terán, Galaviz-Hernandez C., Gil J.P., Isabel Hernández, Lara-Riegos J., Molina-Guarneros J.A., Moya G.E., Nair S., Penãs-Lledó E.M., Rägo L., Ramírez-Roa R., Sosa-Macías M.G., Tarazona-Santos E.M., Verde I.Fuentes:googlescopusAn Appeal to the Global Health Community for a Tripartite Innovation: An "essential Diagnostics List," "health in All Policies," and "see-Through 21<sup>st</sup> Century Science and Ethics"
ReviewAbstract: Diagnostics spanning a wide range of new biotechnologies, including proteomics, metabolomics, and naPalabras claves:Autores:Adrián LLerena, Barlas Ö., Birch K., Boehme C., Borda-Rodriguez A., Byne W.M., Chaverneff F., Coşkun Y., Dahl M.L., Dereli T., Diwakar S., Dove E.S., Elbeyli L., Endrenyi L., Eroʇlu-Kesim B., Ferguson L.R., Güngör K., Gürsoy U.K., Hekim N., Huzair F., Kaushik K., Kickbusch I., Klroʇlu O., Kolker E., Könönen E., Lin B., Malhan F., Nair B., Özdemir V., Patrinos G.P., Sardaş S., Sert Ö., Srivastava S., Steuten L.M.G., Toraman C., Vayena E., Wang W., Warnich L.Fuentes:scopus